AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$80,461
-0.75%
Shares
Shares Volume: 3,669 Shares
Average Share Price: $21.93
INSIDER
Readnour Robin Shane
Director
reported on Jan 12 2024
traded on Jan 10 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 485,792 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $80,461.17 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 2 / 30 |
| P/S VALUE RATIO | 3.697 |
| AVERAGE SALE VALUE | $144,747.66 |
| COMPANY PREVIOUS TRADES |